Top 5 Self-therapy and Journaling Apps on Android in Brazil Q3 2022

During the third quarter of 2022, the top self-therapy and journaling apps on the Android platform in Brazil showcased notable trends in downloads, revenue, and active user engagement. Here’s a closer look at the performance of the leading five apps, based on data from Sensor Tower.

My Diary - Daily Diary Journal experienced a consistent weekly revenue pattern, peaking at approximately $214 in early July and ending the quarter with around $151. Weekly downloads fluctuated, with a significant rise to 18.4K in the last week of September. Active users saw a high of 263K in early September, before declining to 237K by the end of the quarter.

Psychological tests. witnessed a gradual decline in weekly revenue, starting at $82 at the end of June and dropping to $30 by the end of September. Downloads also saw a downward trend, from 18K in late June to 5.8K by the end of the quarter. Active users mirrored this decline, starting at 25K and reducing to 9.2K over the same period.

I am - Daily affirmations showed a steady increase in weekly revenue, reaching $192 by the final week of September. Downloads saw significant growth, peaking at 11.9K in mid-September before slightly dropping to 11.4K at the end of the month. Active users remained relatively stable, fluctuating around the 50K mark throughout the quarter.

Fabulous Daily Routine Planner had a notable revenue peak of $876 in early July, with some fluctuations throughout the quarter, ending at $745. Downloads were highest in late July with 9.6K, and active users varied, peaking at 65.6K in early August and settling at 54.1K by the end of September.

Mininote saw its weekly revenue peak at $16 in late August, before declining towards the end of September. Downloads hit a high of 20.6K in mid-August but fell to zero by the end of the quarter. Active users peaked at 33.4K in late August, with a decline to 9.3K by the end of September.

For more detailed insights and data on these apps, visit Sensor Tower.